Doubling of Decipher Biopsy Genomic Score Is Related to Disease Reclassification on Subsequent Surveillance Biopsy but Not Adverse Features on Radical Prostatectomy

The utility of serial Decipher biopsy scores in a true active surveillance population is still unknown. In a man on active surveillance for low-risk prostate cancer, a doubling of the Decipher biopsy score within genomic low-risk category from first to the second biopsy related to biopsy reclassific...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghabili, Kamyar, Paulson, Nathan, Syed, Jamil S., Nawaf, Cayce B., Khajir, Ghazal, Martin, Darryl T., Onofrey, John, Leapman, Michael S., Levi, Angelique, Weinreb, Jeffrey C., Humphrey, Peter A., Sprenkle, Preston C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054861/
https://www.ncbi.nlm.nih.gov/pubmed/33936831
http://dx.doi.org/10.1155/2021/2687416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054861/
https://www.ncbi.nlm.nih.gov/pubmed/33936831
http://dx.doi.org/10.1155/2021/2687416

Ejemplares similares